Clinical Trial Update: The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in Asian patients with advanced-stage cancer is exploring pharmacokinetic-guided dosing of 5-fluorouracil to optimize drug exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Cancer (Advanced Stage) | Phase 2 | Status: UNKNOWN